Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

New acne cream brings new meaning to ‘adding value to dairy’

New acne cream brings new meaning to ‘adding value to dairy’

Hamilton, 16 June 2014 – Hamilton company, Quantec Personal Care, believes Cleopatra may have been onto something when she bathed in milk.

The research focused company has developed a clinically-proven anti-acne cream whose active, patented ingredient is derived from New Zealand cow’s milk.

The company believes this breakthrough skincare product, marketed under the Epiology brand, is a world first in its category and represents an entirely new approach to improving acne and problem skin.

Quantec founder and Managing Director, Dr Rod Claycomb, explains, “The bioactive enzymes and proteins found in our Epiology anti-acne cream are essentially the same active enzymes and proteins that all mammals produce to protect themselves from potentially harmful bacteria and other microorganisms.

“These enzymes and proteins all work together and make up the essential components of the body’s immune defence system. They naturally occur and provide a protective function in saliva and around gums, tears, raw milk and throughout the gut. This raw ingredient – which we call IDP® - is the key component of the Epiology acne cream.”

He says IDP® has unique properties which makes it very powerful against certain types of disease-causing bacteria. When applied to the skin, it leaves the natural and beneficial bacteria of the skin largely unaffected.

“By leaving these natural and beneficial bacteria active on the skin, IDP® creates an ideal scenario for management of acne. In addition, these bio-proteins interact with inflamed tissues and cells to help quell the inflammatory response, which is a primary cause of acne,” said Dr Claycomb.

It has taken the Quantec research and development team seven years to create IDP® and now prove its efficacy for acne.

During 2012 Quantec completed randomised, double-blinded trials on 84 subjects with mild to moderate acne in the United States. The performance of the milk-ingredient based Epiology cream was compared against two other formulations with FDA-approved acne active ingredients: a leading US retail brand of acne product containing 2% salicylic acid plus retinol and another salicylic acid-based formulation.

After six weeks, both the leading US brand and Epiology demonstrated exactly the same results in reducing acne lesions. However, the Epiology cream demonstrated superior results in the overall reduction of acne related redness and inflammation.

“Our clinical trial results demonstrated the benefits of using Epiology acne cream as a new product for acne prone skin. The study showed Epiology provided subjects with a clearer and brighter complexion without irritation or redness and is particularly suitable for those with sensitive skin,” explained Dr Claycomb.

The Epiology range of products is being sold in pharmacies throughout New Zealand.

About Quantec Ltd and Quantec Personal Care Ltd
Based at the Waikato Innovation Park in Hamilton, New Zealand, Quantec Personal Care Ltd is a wholly owned subsidiary of Quantec Ltd and was established in 2013, to commercialise innovative new consumer products that use IDP® as their active ingredient. Epiology Skincare is the first product range to be launched.

Quantec Ltd is a company specialising in the discovery and commercialisation of high-value bioactives from natural products. Quantec discovered and patented its novel milk fraction, comprised of native immune defense proteins (IDP®) that has proven antimicrobial and anti-inflammatory properties. The research and development team at Quantec Ltd is continually investigating new uses for IDP® in both human and animal applications.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Primary Sector Council Report: Vision To Unite The Primary Sector Launched

Agriculture Minister Damien O’Connor has welcomed the release of a bold new vision for the country’s vital food and fibre sector. More>>

ALSO:

Crown Accounts: Treasury HYEFU Sees Deficit Then Rising Surpluses

An operating balance before gains and losses deficit of $0.9 billion is forecast in the current year, before returning to a small surplus in 2020/21 which then grows to reach $5.9 billion (1.5% of GDP) in 2023/24. More>>

ALSO:

Fuels Rushing In: Govt "Ready To Act" On Petrol Market Report

The Government will now take the Commerce Commission’s recommendations to Cabinet...
• A more transparent wholesale pricing regime • Greater contractual freedoms and fairer terms • Introducing an enforceable industry code of conduct • Improve transparency of premium grade fuel pricing... More>>

ALSO:

Reserve Bank Capital Review Decision: Increased Bank Capital Requirements

Governor Adrian Orr said the decisions to increase capital requirements are about making the banking system safer for all New Zealanders, and will ensure bank owners have a meaningful stake in their businesses. More>>

ALSO: